.jpg)
4 hours ago
1
The New York Yankees tried trading Marcus Stroman in the offseason, but nothing materialized. He has struggled again this year and is on the injured list.
However, according to USA Today's Bob Nightengale, his injury is helping his trade value. Stroman signed a two-year, $37 million deal before the 2024 season and has a vesting option for 2026 that kicks in if he pitches 140 innings this year.
"Yankees starter Marcus Stroman’s trade value is actually increasing by being on the injured list. Now that he’s sidelined, he won’t be able to automatically exercise his player option since he’ll fall short of 140 innings," wrote Nightengale.
"There were several teams that had interest in Stroman during the winter but balked at the possibility of being on the hook for $18 million in 2026," he continued.
Stroman was an All-Star in 2023, but has not lived up to his contract since joining the Yankees. He has a 4.72 ERA since joining the team. This year, he has an 11.57 ERA in three starts. The Yankees were originally trying to move him, but injuries in the rotation during spring training actually kept him in the team's plans.
Follow The Sporting News On WhatsApp
He is currently on the injured list with a knee injury. The Yankees have needs on the infield and the rotation. They could package Stroman in a trade to help their team elsewhere. There will not be many teams running to the phones to get Stroman, but the fact that he is not continuing to inflate his ERA helps the Yankees.
More MLB: Yankees' Jazz Chisholm Jr. breaks silence on beef between Juan Soto and team
English (US)